[Recommendations for the use of infliximab (Remicade) in Crohn's disease. GETECCU 2001].
Domènech
E
E
Hospital Universitari Germans Trías i Pujol, Badalona, Barcelona, Spain. domenech@ns.hugtip.scs.es
Esteve-Comas
M
M
Gomollón
F
F
Hinojosa
J
J
Obrador
A
A
Panés
J
J
Gassull
M A
MA
D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000627:therapeutic use*; D000075202:Contraindications; D003424:Crohn Disease / Q000188:drug therapy* / Q000503:physiopathology; D005765:Gastrointestinal Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D000069285:Infliximab; D014409:Tumor Necrosis Factor-alpha
D000911:Antibodies, Monoclonal; D005765:Gastrointestinal Agents; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab